S Vavricka

1.5k total citations
27 papers, 649 citations indexed

About

S Vavricka is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, S Vavricka has authored 27 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 10 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in S Vavricka's work include Inflammatory Bowel Disease (15 papers), Eosinophilic Esophagitis (7 papers) and Microscopic Colitis (7 papers). S Vavricka is often cited by papers focused on Inflammatory Bowel Disease (15 papers), Eosinophilic Esophagitis (7 papers) and Microscopic Colitis (7 papers). S Vavricka collaborates with scholars based in Switzerland, United States and Germany. S Vavricka's co-authors include Ekaterina Safroneeva, Alain Schoepfer, Alex Straumann, Gerhard Rogler, Antoine Reinhard, Michael Scharl, Laurent Peyrin‐Biroulet, Michael Fried, Nicolas Fournier and Andreas Nydegger and has published in prestigious journals such as Gut, BMJ and Thorax.

In The Last Decade

S Vavricka

24 papers receiving 636 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Vavricka Switzerland 12 275 236 169 153 149 27 649
Florent Gonzalez France 9 361 1.3× 317 1.3× 135 0.8× 457 3.0× 134 0.9× 18 840
Aykut Ferhat Çelık Türkiye 15 170 0.6× 129 0.5× 167 1.0× 125 0.8× 74 0.5× 51 594
Rosalind Sim United Kingdom 7 244 0.9× 248 1.1× 110 0.7× 185 1.2× 90 0.6× 9 632
Luca Moroni Italy 11 146 0.5× 74 0.3× 177 1.0× 162 1.1× 109 0.7× 41 641
Badr Al‐Bawardy United States 14 247 0.9× 227 1.0× 42 0.2× 260 1.7× 87 0.6× 89 665
Deepa Reddy United States 10 172 0.6× 254 1.1× 44 0.3× 217 1.4× 184 1.2× 13 639
E Quintanilla Spain 16 261 0.9× 126 0.5× 69 0.4× 145 0.9× 111 0.7× 52 681
Stephen B. Hanauer United States 7 213 0.8× 407 1.7× 96 0.6× 221 1.4× 99 0.7× 7 597
Jacob Broder Brodersen Denmark 10 111 0.4× 223 0.9× 34 0.2× 133 0.9× 153 1.0× 25 481
Zarife Kuloğlu Türkiye 14 208 0.8× 160 0.7× 33 0.2× 194 1.3× 218 1.5× 82 713

Countries citing papers authored by S Vavricka

Since Specialization
Citations

This map shows the geographic impact of S Vavricka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Vavricka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Vavricka more than expected).

Fields of papers citing papers by S Vavricka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Vavricka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Vavricka. The network helps show where S Vavricka may publish in the future.

Co-authorship network of co-authors of S Vavricka

This figure shows the co-authorship network connecting the top 25 collaborators of S Vavricka. A scholar is included among the top collaborators of S Vavricka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Vavricka. S Vavricka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Novacek, Gottfried, Petr Hrúz, Christoph Högenauer, et al.. (2024). P809 VARIETY BEACH: Real-world treatment patterns for vedolizumab intravenous and subcutaneous maintenance dosing observed over 1 year in studies from Belgium, Austria and Switzerland. Journal of Crohn s and Colitis. 18(Supplement_1). i1496–i1497. 1 indexed citations
2.
Magro, Fernando, Jean‐François Rahier, Cândida Abreu, et al.. (2021). Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do's and Don'ts from the ECCO-COVID Taskforce (vol 14, pg s798, 2020). 15(4). 696–696. 4 indexed citations
3.
Magro, Fernando, Cândida Abreu, Eithne MacMahon, et al.. (2020). Inflammatory Bowel Disease Management During the COVID-19 Outbreak: The Ten Do’s and Don’ts from the ECCO-COVID Taskforce. Journal of Crohn s and Colitis. 14(Supplement_3). S798–S806. 65 indexed citations
4.
Adamina, Michel, Konstantinos Gerasimidis, Rotem Sigall Boneh, et al.. (2020). DOP05 Perioperative Dietary Therapy in inflammatory bowel disease. Journal of Crohn s and Colitis. 14(Supplement_1). S044–S044. 2 indexed citations
5.
Vieujean, Sophie, Annick Moens, Katja Rothfuss, et al.. (2019). P697 Pneumocystis jirovecii pneumonia in IBD patients treated with immunomodulator(s). Journal of Crohn s and Colitis. 13(Supplement_1). S468–S469.
6.
Schreiner, Philipp, Bahtiyar Yılmaz, Yannick Franc, et al.. (2018). P855 Vegetarian and gluten-free diet in patients with IBD—associated with a different microbiota compared with omnivore IBD patients. Journal of Crohn s and Colitis. 12(supplement_1). S549–S549. 2 indexed citations
7.
8.
Lang, Brian M., Luc Biedermann, Wouter T. van Haaften, et al.. (2017). Genetic polymorphisms associated with smoking behaviour predict the risk of surgery in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics. 47(1). 55–66. 16 indexed citations
9.
Safroneeva, Ekaterina, S Vavricka, Nicolas Fournier, et al.. (2015). Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients. Alimentary Pharmacology & Therapeutics. 42(5). 540–548. 18 indexed citations
10.
Spalinger, Marianne R., Siegfried Kasper, Christophe Chassard, et al.. (2014). PTPN2 controls differentiation of CD4+ T cells and limits intestinal inflammation and intestinal dysbiosis. Mucosal Immunology. 8(4). 918–929. 85 indexed citations
11.
Wildi, Stephan M., Alain Schoepfer, S Vavricka, et al.. (2012). Colorectal polypectomy during insertion and withdrawal or only during withdrawal? A randomized controlled trial. Endoscopy. 44(11). 1019–1023. 18 indexed citations
12.
Pohl, Daniel, et al.. (2011). Diagnosing lactase deficiency in three breaths. European Journal of Clinical Nutrition. 65(5). 614–618. 6 indexed citations
13.
Dignaß, Axel, Anders Eriksson, Anders Kilander, et al.. (2010). Clinical trial: five or ten cycles of granulocyte–monocyte apheresis show equivalent efficacy and safety in ulcerative colitis. Alimentary Pharmacology & Therapeutics. 31(12). 1286–1295. 28 indexed citations
14.
Scharl, Michael, Declan F. McCole, Achim Weber, et al.. (2010). Protein tyrosine phosphatase N2 regulates TNFα-induced signalling and cytokine secretion in human intestinal epithelial cells. Gut. 60(2). 189–197. 67 indexed citations
15.
Heinrich, Henriette, Oliver Goetze, D. Menne, et al.. (2010). Effect on gastric function and symptoms of drinking wine, black tea, or schnapps with a Swiss cheese fondue: randomised controlled crossover trial. BMJ. 341(dec14 2). c6731–c6731. 21 indexed citations
16.
Hochholzer, Willibald, et al.. (2008). Diffuse Bauchschmerzen und Eosinophilie. Der Internist. 49(11). 1379–1382. 1 indexed citations
17.
Bauerfeind, Peter, et al.. (2006). Bedside sonographic control for positioning enteral feeding tubes: a controlled study in intensive care unit patients. Endoscopy. 38(12). 1256–1260. 10 indexed citations
18.
19.
Vavricka, S, Jörg Halter, Lukas Hechelhammer, & Andreas Himmelmann. (2004). Pneumocystis carinii pneumonia in chronic lymphocytic leukaemia. Postgraduate Medical Journal. 80(942). 236–238. 4 indexed citations
20.
Vavricka, S. (2003). Pulmonary granulomas after tumour necrosis factor alpha antagonist therapy. Thorax. 58(3). 278–279. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Florent Gonzalez Breakdown of academic impact, for papers by Aykut Ferhat Çelık Breakdown of academic impact, for papers by Rosalind Sim Breakdown of academic impact, for papers by Luca Moroni Breakdown of academic impact, for papers by Badr Al‐Bawardy Breakdown of academic impact, for papers by Deepa Reddy Breakdown of academic impact, for papers by E Quintanilla Breakdown of academic impact, for papers by Stephen B. Hanauer Breakdown of academic impact, for papers by Jacob Broder Brodersen Breakdown of academic impact, for papers by Zarife Kuloğlu
Rankless by CCL
2026